Abstract
Purpose
Intraoperative methadone has been shown to decrease opioid medication requirement following posterior spinal fusion (PSF) for adolescent idiopathic scoliosis (AIS). No study to date has investigated the effect of methadone on opioid medication requirement when used in conjunction with an enhanced recovery after surgery (ERAS) protocol following PSF.
Methods
A retrospective cohort study was performed at a single, tertiary care pediatric hospital. Patients with AIS undergoing PSF were consecutively given a single intra-operative methadone dose and matched 1:2 to a AIS control group without methadone. Patients were matched for age, curve magnitude, levels fused, blood loss, and operating time. All children followed a standard ERAS protocol with methadone being the only change in the post-operative regimen. In-hospital data for opioid and non-opioid medication use, surgical, and patient variables were recorded and compared between cohorts.
Results
Twenty-six patients received methadone (average 15.1 ± 1.9 years) and were matched with 52 control patients without methadone (average 14.7 ± 2.2 years). There were no significant differences in total opioid usage at any time-interval prior to hospital discharge or in cumulative opioid usage. Additionally, patients had a similar VAS pain level at discharge (methadone: 4.0 ± 2.3 vs control: 3.8 ± 1.9; P = 0.572). Total opioid usage was correlated with LOS. There were no opioid-related medication complications in either cohort.
Conclusion
There was no decrease of in-hospital opioid usage when methadone was used with an ERAS protocol. Total opioid usage is correlated with hospital LOS following PSF.
Similar content being viewed by others
References
Yang S, Werner BC (2019) Risk factors for prolonged postoperative opioid use after spinal fusion for adolescent idiopathic scoliosis. J Pediatr Orthop 39(10):500–504
Martin BD, Pestieau SR, Cronin J, Gordish-Dressman H, Thomson K, Oetgen ME (2020) Factors affecting length of stay after posterior spinal fusion for adolescent idiopathic scoliosis. Spine Deform 8(1):51–56
Fletcher ND, Andras LM, Lazarus DE et al (2017) Use of a novel pathway for early discharge was associated with a 48% shorter length of stay after posterior spinal fusion for adolescent idiopathic scoliosis. J Pediatr Orthop 37(2):92–97
Sanders AE, Andras LM, Sousa T, Kissinger C, Cucchiaro G, Skaggs DL (2017) Accelerated discharge protocol for posterior spinal fusion patients with adolescent idiopathic scoliosis decreases hospital postoperative charges 22. Spine (Phila Pa 1976) 42(2):92–97
Gornitzky AL, Flynn JM, Muhly WT, Sankar WN (2016) A rapid recovery pathway for adolescent idiopathic scoliosis that improves pain control and reduces time to inpatient recovery after posterior spinal fusion. Spine Deform 4(4):288–295
Sucato DJ, Lovejoy JF, Agrawal S, Elerson E, Nelson T, McClung A (2008) Postoperative ketorolac does not predispose to pseudoarthrosis following posterior spinal fusion and instrumentation for adolescent idiopathic scoliosis. Spine (Phila Pa 1976) 33(10):1119–1124
Anderson DE, Duletzke NT, Pedigo EB, Halsey MF (2020) Multimodal pain control in adolescent posterior spinal fusion patients: a double-blind, randomized controlled trial to validate the effect of gabapentin on postoperative pain control, opioid use, and patient satisfaction. Spine Deform 8(2):177–185
Trzcinski S, Rosenberg RE, Vasquez Montes D et al (2019) Use of gabapentin in posterior spinal fusion is associated with decreased postoperative pain and opioid use in children and adolescents. Clin Spine Surg 32(5):210–214
Li MM, Ocay DD, Teles AR et al (2019) Acute postoperative opioid consumption trajectories and long-term outcomes in pediatric patients after spine surgery. J Pain Res 12:1673–1684
Fletcher ND, Shourbaji N, Mitchell PM, Oswald TS, Devito DP, Bruce RW (2014) Clinical and economic implications of early discharge following posterior spinal fusion for adolescent idiopathic scoliosis. J Child Orthop 8(3):257–263
Murphy GS, Avram MJ, Greenberg SB et al (2020) Postoperative pain and analgesic requirements in the first year after intraoperative methadone for complex spine and cardiac surgery. Anesthesiology 132(2):330–342
Komen H, Brunt LM, Deych E, Blood J, Kharasch ED (2019) Intraoperative methadone in same-day ambulatory surgery: a randomized, double-blinded, dose-finding pilot study. Anesth Analg 128(4):802–810
Murphy GS, Szokol JW, Avram MJ et al (2015) Intraoperative methadone for the prevention of postoperative pain: a randomized, double-blinded clinical trial in cardiac surgical patients. Anesthesiology 122(5):1112–1122
Martin DP, Samora WP 3rd, Beebe AC et al (2018) Analgesic effects of methadone and magnesium following posterior spinal fusion for idiopathic scoliosis in adolescents: a randomized controlled trial. J Anesth 32(5):702–708
Center for Disease Control. Calculating total daily dose of opioids for safer dosage. https://www.cdc.gov/drugoverdose/pdf/calculating_total_daily_dose-a.pdf. Accessed 10 Jan 2021
Connelly M, Fulmer RD, Prohaska J et al (2014) Predictors of postoperative pain trajectories in adolescent idiopathic scoliosis. Spine (Phila Pa 1976) 39(3):E174–E181
Ocay DD, Li MMJ, Ingelmo P, Ouellet JA, Pagé MG, Ferland CE (2020) Predicting acute postoperative pain trajectories and long-term outcomes of adolescents after spinal fusion surgery. Pain Res Manag 2020:9874739
Hwang SW, Pendleton C, Samdani AF et al (2020) Preoperative SRS pain score is the primary predictor of postoperative pain after surgery for adolescent idiopathic scoliosis: an observational retrospective study of pain outcomes from a registry of 1744 patients with a mean follow-up of 3.4 years. Eur Spine J 29(4):754–760
Muhly WT, Sankar WN, Ryan K et al (2016) Rapid recovery pathway after spinal fusion for idiopathic scoliosis. Pediatrics 137(4):e20151568. https://doi.org/10.1542/peds.2015-1568
Stemland CJ, Witte J, Colquhoun DA et al (2013) The pharmacokinetics of methadone in adolescents undergoing posterior spinal fusion. Paediatr Anaesth 23(1):51–57
Gottschalk A, Durieux ME, Nemergut EC (2011) Intraoperative methadone improves postoperative pain control in patients undergoing complex spine surgery. Anesth Analg 112(1):218–223
Yu EH, Tran DH, Lam SW, Irwin MG (2016) Remifentanil tolerance and hyperalgesia: short-term gain, long-term pain? Anaesthesia 71(11):1347–1362
Funding
Implants for this study were provided by OrthoPediatrics.
Author information
Authors and Affiliations
Contributions
AS: Data Analysis, Data Interpretation, Manuscript drafting, Manuscript Approval. NDF: Study Design, Data Analysis, Data Interpretation, Manuscript drafting, Manuscript Approval. DPD: Study design, Data Interpretation, Manuscript editing, Manuscript Approval. MLS: Study design, Data Interpretation, Manuscript editing, Manuscript Approval. JF: Study design, Data Interpretation, Manuscript editing, Manuscript Approval. SG: Data Acquisition, Study Design, Manuscript editing, Manuscript Approval. PC: Data Acquisition, Study Design, Manuscript editing, Manuscript Approval. JSM: Study design, Data Interpretation, Manuscript editing, Manuscript Approval.
Corresponding author
Ethics declarations
Conflict of interest
Dr. Shaw is a committee member for NASS; Dr. Fletcher is a paid consultant for Medtronic, is a unpaid consultant for OrthoPediatrics, is a paid speaker for Nuvasive, Zimmer, Medtronic, and OrthoPediatrics, is a committee member for SRS and POSNA, Dr Devito receives royalties from Astura Spine, Medicrea, and SeaSpine, is a paid consultant for Sea Spine, Medicrea, receives research support from K2M, Mazor surgical technologies, received material support from K2M, Medtronic, and is a paid speaker for Medicrea; Dr. Schmitz is a consultant for Stryker, OrthoPediatrics and a board member for Journal of Pediatric Orthopedics, POSNA, and Scoliosis Research Society; Dr. Fabregas is a consultant for Astura Medical, Ms Gidwani has nothing to disclose; Dr. Chhatbar has nothing to disclose; Dr. Murphy is a consultant for Depuy and OrthoPediatrics, receives research support from OrthoPediatrics, and board member for Journal of Pediatric Orthopedics, POSNA, Spine Journal, Journal of Spine Deformity, and Scoliosis Research Society.
Ethical approval
This study was approved by the Institutional Review Board at Children’s Healthcare of Atlanta, Scottish Rite IRB Review.
Informed consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the views of the Department of Defense or US Government. The authors are employees of the US government. This work was prepared as part of their official duties and, as such there is no copyright to be transferred.
Rights and permissions
About this article
Cite this article
Shaw, K.A., Fletcher, N.D., Devito, D.P. et al. In-hospital opioid usage following posterior spinal fusion for adolescent idiopathic scoliosis: Does methadone offer an advantage when used with an ERAS pathway?. Spine Deform 9, 1021–1027 (2021). https://doi.org/10.1007/s43390-021-00288-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43390-021-00288-5